Bristol-Myers Squibb Co (WBO:BMYS) Ending Cash Position : €9,881 Mil (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Bristol-Myers Squibb Co Ending Cash Position?

Bristol-Myers Squibb Co's Ending Cash Position for the quarter that ended in Dec. 2024 was €9,881 Mil.

Bristol-Myers Squibb Co's quarterly Ending Cash Position increased from Jun. 2024 (€5,849 Mil) to Sep. 2024 (€7,112 Mil) and increased from Sep. 2024 (€7,112 Mil) to Dec. 2024 (€9,881 Mil).

Bristol-Myers Squibb Co's annual Ending Cash Position increased from Dec. 2022 (€8,803 Mil) to Dec. 2023 (€10,563 Mil) but then declined from Dec. 2023 (€10,563 Mil) to Dec. 2024 (€9,881 Mil).

Bristol-Myers Squibb Co Ending Cash Position Historical Data

The historical data trend for Bristol-Myers Squibb Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Ending Cash Position Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

12,307.81

12,669.66

8,802.80

10,562.92

9,881.39

Bristol-Myers Squibb Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															10,562.92	8,587.28	5,848.98	7,111.59	9,881.39

Bristol-Myers Squibb Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Bristol-Myers Squibb Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	11000.645	+	-1119.26
	=	9,881

Bristol-Myers Squibb Co's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	7537.815	+	2343.57
	=	9,881

Bristol-Myers Squibb Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (WBO:BMYS) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BRM:Germany BRM:Germany BRM:Germany BMYB34:Brazil BMY:Argentina

Address

Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Bristol-Myers Squibb Co Headlines

No Headlines